Anti-angiogenesis Combined With PD-1/PD-L1 Therapy in Patients With Advanced Liver Cancer
Clinical trial NCT05383066 · UNKNOWN
Trial details
- NCT number
- NCT05383066
- Sponsor
- Peking University First Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-05-20
- Primary completion
- 2023-12-30
- Enrollment
- 490
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.